ACM
MDXG icon

Advisors Capital Management’s MiMedx Group MDXG Stock Holding History

Advisors Capital Management’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-20,000
Closed -$250K – 411
2021
Q2 		$250K Buy
+20,000
New +$217K 0.01% 353

Other funds holding MDXG

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return

Advisors Capital Management's MDXG Position: Q3 2021 in Review

Advisors Capital Management sold out of MiMedx Group (MDXG) in Q3 2021, closing a stake of 20,000 shares — an estimated $250K sold.

Advisors Capital Management first reported a position in MDXG in Q2 2021 and held it in 1 quarter. The position peaked at $250K in Q2 2021. 142 funds tracked by Wall St. Rank hold MDXG as of Q3 2021.

  • Advisors Capital Management reported no remaining MiMedx Group position as of Q3 2021 after selling out during the quarter.
  • Advisors Capital Management sold 20,000 MiMedx Group shares in Q3 2021, an estimated $250K.
  • Advisors Capital Management first reported a position in MiMedx Group in Q2 2021 and held it in 1 quarter.
  • Advisors Capital Management's MiMedx Group position peaked at $250K in Q2 2021.
  • 142 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2021.

Based on Advisors Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.